XML 16 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income (loss) attributable to common stockholders $ (80,570) $ 52
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 13,125 12,980
Impairment charge 49,438  
Deferred income taxes 214 (129)
Non-cash interest 160 179
Amortization of syndication contracts 227 240
Payments on syndication contracts (229) (241)
Non-cash stock-based compensation 8,734 10,021
(Gain) loss on marketable securities 109 61
(Gain) loss on disposal of property and equipment 183 18
Loss (gain) on the sale of businesses 45,014  
(Gain) loss on debt extinguishment 91 1,556
Change in fair value of contingent consideration (12,548) (2,942)
Net income (loss) attributable to redeemable noncontrolling interest - discontinued operations (2,779) (12)
Net income (loss) attributable to noncontrolling interest - discontinued operations   (342)
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable 9,586 17,480
(Increase) decrease in prepaid expenses and other current assets, operating leases right of use asset and other assets (19,590) (3,297)
Increase (decrease) in accounts payable, accrued expenses and other liabilities 39,906 11,467
Net cash provided by operating activities 51,071 47,091
Cash flows from investing activities:    
Proceeds from sale of businesses, net of cash divested (42,967)  
Proceeds from sale of assets   50
Purchases of property and equipment (4,737) (14,858)
Purchase of a business, net of cash acquired   (6,930)
Purchases of marketable securities   (10,172)
Proceeds from sale of marketable securities 10,019 28,093
Proceeds from loan receivable 10,748  
Purchases of investments   (200)
Issuance of loan receivable   (8,086)
Net cash provided by (used in) investing activities (26,937) (12,103)
Cash flows from financing activities:    
Proceeds from stock option exercises   554
Tax payments related to shares withheld for share-based compensation plans (27) (95)
Payments on debt (20,275) (213,245)
Dividends paid (8,972) (8,782)
Distributions to noncontrolling interest (1,078) (3,380)
Payment of contingent consideration (14,300) (31,710)
Principal payments under finance lease obligation (74) (76)
Proceeds from borrowings on debt   212,419
Payments for debt issuance costs   (1,777)
Net cash provided by (used in) financing activities (44,726) (46,092)
Effect of exchange rates on cash, cash equivalents and restricted cash (2) 1
Net increase (decrease) in cash, cash equivalents and restricted cash (20,594) (11,103)
Cash, cash equivalents and restricted cash:    
Beginning 106,509 111,444
Ending 85,915 100,341
Cash payments for:    
Interest 8,620 8,155
Income taxes 5,148 3,582
Supplemental disclosures of non-cash investing and financing activities:    
Capital expenditures financed through accounts payable, accrued expenses and other liabilities 1,132 $ 2,097
Note receivable (5,374)  
Dividends equivalents payable $ 1,219